Skip to content

Opening book details…

About this Medicine article

649 Update on the toxicity and response of a phase I trial of concurrent, daily gefitinib and radiation or chemo-radiation for patients with locally advanced squamous cell cancer of the head and neck (LASCCHN) by D. Raben; M. Kane; C. Chen; J. Song; L. Brualdi; A. Raben; K. Hu; S. Gollamudi; H. Quon; J. Dancey is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
D. Raben; M. Kane; C. Chen; J. Song; L. Brualdi; A. Raben; K. Hu; S. Gollamudi; H. Quon; J. Dancey
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
Published
2004
Field
Medicine (Health Sciences)

More by D. Raben; M. Kane; C. Chen; J. Song; L. Brualdi; A. Raben; K. Hu; S. Gollamudi; H. Quon; J. Dancey

Browse all works by D. Raben; M. Kane; C. Chen; J. Song; L. Brualdi; A. Raben; K. Hu; S. Gollamudi; H. Quon; J. Dancey